CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling health care giant.

CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the healthcare conglomerate tasked a new CEO with its turnaround efforts.

CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for changes at the diversified healthcare giant.

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.

CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of the struggling healthcare giant.

CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins. Longtime investor Glenview Capital Management bought 2.

Shares of CVS Health (NYSE:CVS) rose 2.8% in premarket trading on Monday following a report from the Wall Street Journal that the company will expand its board as part of an agreement with Glenview Capital Management,